---  
layout: startup_page  
title: "Accropeutics"  
id: "accropeutics.com"  
permalink: "/accropeuticsaccropeutics.com03142025/"  
website: "http://www.accropeutics.com/"  
funding_round: "Series B+"  
funding_amount: "$12M"  
investors: "Shenzhen Capital Group (SCGC), Morningside Ventures, Leader Venture Investment (SZTI), Hefei Sci-Tec Venture Capital (HFST)"  
about: "Accropeutics Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for immune-mediated inflammatory diseases. The company targets molecular mechanisms of regulated cell death to create potentially best-in-class therapies for a wide range of diseases. Accropeutics has a robust portfolio of compounds in various stages of development, from lead optimization to clinical testing."  
markets: "Biotech, Therapeutics, Pharmaceuticals"  
hq: "New York, New York, United States"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/accro-bioscience"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/accro-bioscience"  
pitchbook: "https://pitchbook.com/profiles/company/489709-90"  

date_display: "14-Mar-2025"  
date: "2025-03-14"

# SEO Optimization  
meta_title: "Accropeutics - Series B+ Funding ($12M)"  
meta_description: "Accropeutics, Accropeutics Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for immune-mediated inflammatory diseases. The co..."  
meta_keywords: "Accropeutics, Biotech, Therapeutics, Pharmaceuticals, Series B+ funding"  
canonical_url: "https://startup.projectstartups.com/accropeuticsaccropeutics.com03142025/"  
---